Back to SA SEB Asset Management AB
ABCL
2 quarters
Position history for SASEB Asset Management AB's holdings in AbCellera Biologics Inc.
No. SEB Asset Management exited its ABCL (AbCellera Biologics) position in Q2 2026. Its Q1 2026 13F listed 340,267 shares worth $1.2M. SEB Asset Management held ABCL in 1 quarterly 13F filing before exiting.
Final Value
$0
Final Shares
0
Total Value Change
-$1.2M
Total Shares Change
-340,267
Quarter-by-Quarter History